With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...

While Metformin continues to be the standard first-line treatment for Type-2 diabetes, newer therapies such as SGLT2 ...

10.03 for one tablet Mankind Pharma IPO: The issue, which is an offer for sale, is expected to fetch the pharma company's shareholders Rs 4,326.36 crore at the upper end of the price band of Rs ...

The maker of popular Manforce condoms and Prega News pregnancy test kits, Mankind Pharma, is developing an oral anti-obesity drug that, if successful, could become the first small-molecule ...

It launched Zukanorm tablets for diabetes pharmaceuticals segment.Another new subsidiary, Mankind Pharma FZ-LLC in Dubai, UAE got incorporated during the year 2021. It launched Mlife tablets in ...

Currently priced at Rs 60 per tablet, Empagliflozin’s generic versions will be available for as low as Rs 9-Rs 14 per tablet, significantly reducing costs for millions of patients, states the report.

January 23, 2025 India's Mankind Pharma misses Q3 profit view as expenses jump India's Mankind Pharma reported a smaller-than-expected third-quarter profit on Thursday, hurt by a sharp rise in ...